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A B S T R A C TObjective: Many studies have documented the high rates of func-
tional impairment among patients with schizophrenia. The majority
of the available instruments used to assess functioning, however,
focus on global measures of functional recovery rather than specific
domains of psychosocial functioning. Most of these instruments have
important limitations regarding use in psychiatry. The aim of the
present study was to evaluate the psychometric properties of the
Brazilian version of the Functioning Assessment Short Test (FAST) in
patients with schizophrenia. Methods: A convenience sample of 107
chronic outpatients with schizophrenia and 108 controls was assessed
in a university hospital (Hospital de Clı´nicas de Porto Alegre, Brazil).
Psychometric properties of FAST (internal consistency, concurrent
validity, and test-retest reliability) were analyzed. Results: The inter-
nal consistency obtained was high; the Cronbach’s alpha was 0.89.
FAST total score was higher in patients than in the control group (Z ¼
11.95; Po 0.001). FAST test-retest agreement was excellent (intraclassnt matter Copyright & 2012, International Society
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.1016/j.vhri.2012.08.001
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ondence to: Karine Zorte´a, Av. Prota´sio Alves 7157/2correlation coefficient ¼ 0.93; 95% confidence interval 0.81–0.97). In
addition, FAST displayed a positive correlation with the Brief Psychia-
tric Rating Scale (r ¼ 0.41; Po 0.001) and a negative correlation with
the Global Assessment of Functioning scale (r ¼ 0.71; P ¼ 0.001).
Conclusions: Psychotic symptoms, comorbidity, and functional and
cognitive impairment contribute to the decreased quality of life of
patients with schizophrenia. It is important to obtain a valid and
reliable instrument that is capable of evaluating the functional
domains in this pathology. In this context, FAST showed accurate
psychometrics properties and was able to detect functional differ-
ences between patients with the diagnosis of schizophrenia and
healthy subjects.
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Schizophrenia (SZ) is characterized by a profound disruption of
cognition and emotion that affects the most fundamental human
attributes: language, thought, perception, affect, and sense of self
[1]. Patients have significant difficulties in adaptive and role
functioning and have problems in basic self-care, interpersonal
interaction, and occupational life [2]. About 80% to 90% of the
patients manifest functional (social or occupational) handicaps
compared with what might be expected on the basis of their
premorbid or familial level of function [3].
Functional handicaps are assessed on the basis of a multi-
dimensional construct that encompasses the abilities to perform
activities of daily living and participate in various life situations
[4]. Many studies have documented high rates of functional
impairment among patients with SZ, including patients in Brazil.
The majority of the available instruments used to assess func-
tioning, however, focus on global measures of functional recovery
rather than specific domains of psychosocial functioning. Most of
the general instruments that assess functioning have importantlimitations regarding use in psychiatry [5]. The most frequently
used interviewer-administered functional measures are global
rating scales, such as the Global Assessment of Functioning (GAF)
scale, which are notorious for failing to distinguish clinical and
functional recovery [6]. Additional domains of functioning, such
as cognition, interpersonal relationships, and autonomy, must be
considered in mental illness for better description of recovery
and impairment.
In this context, the Functioning Assessment Short Test (FAST)
is a brief instrument that was designed to assess the main
functional problems experienced by psychiatric patients. FAST
has been used mainly with patients with bipolar disorder and has
been demonstrated to have good psychometric characteristics for
both the Spanish and Portuguese languages [5,7,8]. Furthermore,
FAST was developed for the clinical evaluation of functional
impairment in patients suffering from mental disorders, and it
is a simple instrument that is easy to apply and requires very
little time to be administered [7]. Thus, the aim of the present
study was to evaluate the validity and reliability of FAST in
Brazilian outpatients with SZ.for Pharmacoeconomics and Outcomes Research (ISPOR).
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Table 1 – Demographic and clinical characteristics.
Characteristic SZ sample
(n ¼ 107)
Control group
(n ¼ 108)
Age (y) 38 (29–46) 37 (27–49.75 )
Years of education 8 (7–11) 11 (8–11)
Length of Illness (y) 17 (7–24) —
Female gender (%)
Smoking status (%) 30.8 40.7
Illicit drug (%) 31.1 18.9
Antipsychotics (%) 4.8 —
Typic
Atypic 23.3 —
Clozapine 19.8 —
Clinical state 56.9 —
BPRS total score 16 (10—24) —
Positive symptoms 3 (0—6) —
Negative symptoms 5 (3—8) —
GAF scale 64 (55—80) —
BPRS, Brief Psychiatric Rating Scale; GAF, Global Assessment of
Functioning; SZ, schizophrenia.
* Median (interquartile range with 95% confidence interval) or
frequency (%).
Table 2 – Discriminant reliability of FAST.
Characteristic SZ sample
(n ¼ 107)
Control
group
(n ¼ 108)
FAST total score 42 (32–51)† 5 (2–11)†
Cronbach’s a
FAST total score 0.89 0.97
FAST autonomy (items 1–4) 0.88 0.97
FAST occupational (items
5–9)
0.87 0.97
FAST cognitive (items 10–14) 0.87 0.97
FAST financial (items 15–16) 0.87 0.97
FAST relationships (items
17–22)
0.88 0.97
FAST leisure (items 23–24) 0.87 0.97
Intraclass correlation 0.93 —
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Outpatients aged between 18 and 60 years with a clinical
diagnosis of SZ according to the criteria of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition [1] were
recruited by convenience from the SZ program at a large uni-
versity hospital (Hospital de Clı´nicas de Porto Alegre, Brazil) and
assessed with FAST and the Brief Psychiatric Rating Scale (BPRS).
Trained raters with the aid of the original scale guide adminis-
tered FAST. Patients with comorbid mental retardation were
excluded. One hundred and eight age- and sex-matched control
subjects were recruited from the same hospital catchment area
as a control group. This group was screened with the nonpatient
version of the Structured Clinical Interview to exclude those with
current psychiatry morbidity and those with first-degree relatives
with psychiatry disorders. The controls were generally family
members of people using other health facilities of the hospital.
The protocol was approved by the Research Ethics Committee of
Hospital de Clı´nicas de Porto Alegre (no. 08-436), and all partici-
pants provided written informed consent before entering
the study.
The FAST Brazilian scale consists of 24 items that allow the
assessment of five specific areas of functioning: autonomy,
occupational functioning, cognitive functioning, financial issues,
and interpersonal relationships. The rater asks the patient about
areas of difficulty in functioning and scores according to the
following scale: (0) no difficulty, (1) mild difficulty, (2) moderate
difficulty, and (3) severe difficulty. Scores are determined by the
sum of the individual items in the preceding 15 days. A semi-
structured manual is used to ensure uniform understanding of
item scoring [5,7].
The BPRS consists of an unstructured interview that includes
the following 18 items: somatic concern, psychic anxiety, emo-
tional withdrawal, conceptual disorganization, feelings of self-
depreciation and guilt, somatic anxiety, specific motor distur-
bances, overly inflated self-esteem, depressive mood, hostility,
suspiciousness, hallucinations, psychomotor retardation, unco-
operativeness, unusual thought content, blunted or inappropriate
affect, psychomotor agitation, and disorientation/confusion. The
BPRS was used to evaluate current symptoms and positive and
negative dimensions (negative scores refer to the sum of ques-
tions 3, 9, 13, and 16, and positive scores refer to the sum of
questions 8, 11, 12, and 15 of the BPRS) [9].
The GAF scale is used to assess global functioning on the basis
of Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition, Axis V criteria. The assessment is based on patient
behavior in the preceding month and uses a continuous scale
ranging from 1 to 100; a score of 1 represents the worst
functioning, and higher scores denote better functioning and
fewer symptoms [6,7].
The internal consistency of FAST was assessed with Cron-
bach’s alpha. Test-retest reliability was calculated in a subsample
(n ¼ 19, patients recruited by convenience of the same original
sample) by the measurement of the intraclass correlation coeffi-
cient. Patients were retested between 6 and 8 months after the
first evaluation by interviewers blinded to the original scores.
Concurrent validity of FAST in comparison with the GAF scale
and correlations of FAST with the BPRS were obtained by Spear-
man’s rho. The Mann-Whitney’s U was used to compare patient
and control group scores.(0.81–0.97)
FAST, Functioning Assessment Short Test; SZ, schizophrenia.
* Median (95% confidence interval).
† Po 0.001 for difference between SZ and control groups for FAST
total score and FAST by domains (Mann-Whitney’s U).Results
One hundred and seven patients and 108 healthy control subjects
were included in this report. Their demographic and clinicalcharacteristics are shown in Table 1. The sample was well
matched in terms of age and gender. The patients had fewer
years of education than the control subjects (median difference
of 3 years; 95% confidence interval 7–11 years in patients and
8–11 years in controls; Z ¼ 3.23; P ¼ 0.001).
Median FAST scores were 42 for patients and 5 for controls
(Z ¼ 11.95; P o 0.001); this finding remained significant after
adjustment for years of education (partial correlation ¼ 0.75;
P o 0.001) (Table 2). FAST scores were separated by domain, and
all domains were different in patients and controls (autonomy
Z ¼ 11.21, occupational Z ¼ 12.60, cognitive Z ¼ 9.72, financial
Z ¼ 12.51, relationships Z ¼ 12.09, leisure Z ¼ 9.31; Po 0.001).
FAST was significantly correlated with the BPRS (r ¼ 0.41;
P o 0.001); this correlation was stronger for the negative symp-
toms subscale (r ¼ 0.36; P o 0.001) than for the positive
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correlated with GAF scale scores (n ¼ 19; r ¼ 0.71; P ¼ 0.001).
Test-retest agreement for FAST was excellent (intraclass cor-
relation coefficient ¼ 0.93; 95% confidence interval 0.81–0.97).
Cronbach’s alpha was 0.88 for the total scale. Details of the
Cronbach’s alpha analysis by domain are shown in Table 2. Items
20 and 21 had the lowest item-total correlations. After removal of
these two items, the alpha went up to 0.89.Discussion
This is the first study evaluating the use of FAST for the
measurement of disability in SZ. In the present study, the
instrument demonstrated good psychometric properties in terms
of validity and reliability that are very similar to those for bipolar
disorder.
The internal consistency coefficient was high, indicating item
homogeneity. Concurrent validity with the GAF scale showed a
highly significant negative correlation. Increased GAF scale
scores indicate adjustment, whereas high FAST scores show
disability; therefore, this result indicates that patients with good
functioning assessed using FAST had higher scores on the GAF
scale. Test-retest showed an excellent intraclass correlation,
although patients were retested between 6 and 8 months after
the first evaluation. The test-retest results are exploratory finding
that need further confirmation in a small subsample and after a
long period of time. FAST total scores were higher in patients
than in controls, which demonstrate the marked difference in
disability among subjects with a diagnosis of SZ compared with
normal controls.
Because patients usually retain residual symptoms despite
highly specialized treatment, it is desirable to quantify the
disability of these patients to develop and improve treatment
choices. When symptom severity increases, patients have more
difficulty than do healthy controls in interpersonal relations, life
activities, participation in society, understanding and commu-
nicating with the world, and getting along with people [10]. One
study emphasized that disability in SZ starts primarily in social
and occupational roles and interpersonal relations, and in more
severe situations self-care begins to be affected [2].
According to a previous study [11], positive and negative
symptoms are highly associated with disability; this finding
reinforces the importance of symptoms in the functional status
of patients. Negative symptoms were more strongly related than
positive symptoms to functional status in this report.
Negative symptoms include apathy, lack of emotion, and poor
social functioning, while cognitive symptoms include disorga-
nized thoughts, difficulty concentrating and/or following instruc-
tions, difficulty completing tasks, and memory problems.
Negative symptoms are more strongly related than positive
symptoms to functional status because of the poor quality of
treatment options for negative symptoms, which often fail to
respond to standard pharmacological therapy. Therefore, novel
specific interventions are necessary as are valid instruments to
gauge their efficacy [12].
Patients with SZ exhibit cognitive difficulties that are very
similar to bipolar disorder in terms of their profile, although SZ
may have more severe and widespread impairments. Compar-
ison of the present results with a study reported by Cacilhas et al.
[5] revealed that FAST total scores were almost two times lower in
patients with euthymic bipolar disorder [5,7], which suggests a
marked functional impairment among patients with SZ. The
resemblance in cognitive profiles has important implications for
the etiology and treatment of both disorders [13]. Our results
show that FAST is as reliable a scale for measuring disability in SZ
as it is in bipolar disorder.Our results also show the applicability of the FAST scale to
patients diagnosed with SZ and a clear difference in the assessment
of healthy controls of similar age, ethnic origin, and gender.
Psychotic symptoms, comorbidities, and functional and cognitive
impairments significantly and independently affect the quality of
life of these patients. Furthermore, there is a dearth of instruments
specifically designed to measure functional status in psychiatric
patients, and it is difficult to compare studies using different
instruments. Therefore, obtaining valid and reliable instruments
that are capable of adequately assessing the functional domains in
SZ and differentiate healthy subjects is extremely important [14].
Several limitations of the present study must be described.
First, we employed a convenience sample that reflects a long-
term medicated population with chronic disease and is not
representative of Brazil. Most of our patients have been followed
up for at least 10 years, and our findings cannot be extrapolated
to prodromic or first psychotic episode populations. New studies
need to examine the disabilities in these phases of SZ. Second,
the educational status varied between patients and controls;
disability has been extensively demonstrated in patients with
SZ in previous studies, but controls who are well matched for
educational status would be necessary to prevent bias. Third,
differences between typical and atypical antipsychotics and daily
drug doses can influence symptoms and functional status.
Fourth, this study did not evaluate the interrater reliability.
Finally, follow-up studies are necessary to evaluate whether
functional impairment and prognoses worsen over years.Conclusions
FAST showed accurate psychometric properties. This study sup-
ports the use of FAST to detect differences between patients with
SZ and healthy subjects in four domains of disability. Our
findings, however, need to be replicated with larger sample sizes
over longer follow-up periods to better evaluate the use of this
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